詢  價
                        
                        
                索取COA
                        
                    產品描述
                    產品數據庫
                    
                | Introduction | |
| Format | Genomic DNA | 
| Description | β-thalassemia (β-mediterraneananemia) refers to the A group of hemoglobinopathies in which synthesis is partially or completely inhibited. | 
| Technical Data | |
| Mutation 1 | Variation site: IVS-I-6(T>C) | 
| DNA Change: c.92+6T>C | |
| Zygosity: Heterozygous | |
| Allelic Frequency: 50% | |
| Chr position(GRCh37): Chr11:5248154A>G | |
| Transcript: NM_000518.5 | |
| Mutation2 | Variation site: IVS-II-745(C>G) | 
| DNA Change: c.316-106C>G | |
| Zygosity: Heterozygous | |
| Allelic Frequency: 50% | |
| Chr position(GRCh37): Chr11:5247062G>C | |
| Transcript: NM_000518.5 | |
| Buffer | Tris-EDTA | 
| Product Information | |
| Intended Use | Research Use Only | 
| Unit Size | 1ug | 
| Concentration | Download for COA | 
| Purofication | Download for COA | 
| DNA electrophoresis | Download for COA | 
| Sanger sequencing | 
				 
 
  | 
		
| Storage | 2-8℃ | 
| Expiry | 36 months from the date of manufacture | 
            
